Description:
Antiserum IP is a life-saving pharmaceutical product used to neutralize venom from poisonous snake bites. It is a biological product derived from the blood of healthy horses that have been immunized against specific snake venoms and its also a polyvalent, fast-acting biological antiserum used for the emergency treatment of envenomation from venomous snakes like Cobras, Kraits, and Vipers.Â
Prescription:Â
Prescription-only medication.Â
Therapeutic Category:Â
- Antivenom / Biological Product / Blood Derivative.Â
Active Ingredients/Composition:Â
- Purified immunoglobulins (antibodies) obtained from the plasma of hyperimmunized horses (equines). It typically contains refined fragments.Â
Variant:Â
- Available as a 10ml vial, often in a lyophilized (freeze-dried) powder form or as a liquid.Â
Consume Type:Â
- Intravenous (IV) or Intramuscular (IM) injection (IV is generally preferred for severe cases).Â
Directions/Usage:Â Must be administered by a doctor or trained healthcare professional.
- Lyophilized form:Â Must be reconstituted with Sterile Water for Injection (often supplied in a 10ml vial).
- Dosage:Â Determined by the clinician based on the severity of the bite and the patient’s symptoms.Â
Common Side Effects:Â
- Early or late allergic reactions (itching, rash, fever, or joint pain) and potentially severe anaphylaxis.Â
Package Type:Â
- Sterile glass vial, often 10ml in size.Â
Storage Advice:Â
- Store in a cool, dry place, typically below 25°C or 30°C depending on the specific manufacturer’s instruction. Lyophilized forms are generally more stable at room temperature but should avoid excessive heat.Â
Safety Advice:
- Adrenaline should always be kept ready before administration to treat potential allergic reactions.
- Monitor vitals closely during and after infusion.
- Pregnancy is not a contraindication given the life-threatening nature of snake bites.Â
Product Substitutes:Â
- Other polyvalent snake antivenoms from manufacturersÂ
Manufacturer/Marketer:Â
Country of Origin:Â
Reviews
There are no reviews yet.